OncoDiag Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3.01M

  • Investors
  • 6

OncoDiag General Information

Description

Developer of non-invasive diagnostic testing kits designed to help in the early detection of urological cancers. The company's testing kits consist of a urine-based lab test for the surveillance of bladder cancer, a tissue-based lab test to predict non-evolutive localized prostate cancer, and a blood-based lab test for screening colorectal cancer, enabling doctors to effectively proceed in cancer diagnostics.

Contact Information

Website
www.oncodiag.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9 Rue de Pacy
  • 27930 Miserey
  • France
+33 02
Primary Industry
Diagnostic Equipment
Other Industries
Clinics/Outpatient Services
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 9 Rue de Pacy
  • 27930 Miserey
  • France
+33 02

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoDiag Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 15-Mar-2021 $3.01M Completed Generating Revenue
3. Angel (individual) 14-Dec-2018 Completed Generating Revenue
2. Angel (individual) 06-Jun-2017 $207K $207K Completed Generating Revenue
1. Accelerator/Incubator 05-Jun-2014 Completed Generating Revenue
To view OncoDiag’s complete valuation and funding history, request access »

OncoDiag Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 9,300 $1.204024 $24.08 $24.08 1x $24.08 5.96%
To view OncoDiag’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OncoDiag Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-invasive diagnostic testing kits designed to help in the early detection of urological cancers. The com
Diagnostic Equipment
Miserey, France
5 As of 2025

Irvine, CA
 

Pleasanton, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoDiag Competitors (5)

One of OncoDiag’s 5 competitors is OncoCyte, a Formerly VC-backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OncoCyte Formerly VC-backed Irvine, CA
DiaCarta Venture Capital-Backed Pleasanton, CA
Owlstone Medical Venture Capital-Backed Cambridge, United Kingdom
Nucleix Venture Capital-Backed Rehovot, Israel
Biodesix Formerly VC-backed Louisville, CO
You’re viewing 5 of 5 competitors. Get the full list »

OncoDiag Patents

OncoDiag Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2730710-T3 Methods for surveillance, diagnosis and exploration of bladder cancer (bladder) Active 19-Nov-2013
US-11060152-B2 Methods for the surveillance, diagnosis and screening of bladder cancer Active 19-Nov-2013
US-20190062849-A1 Methods for the surveillance, diagnosis and screening of bladder cancer Active 19-Nov-2013
US-20160273048-A1 Methods for the surveillance, diagnosis and screening of bladder cancer Inactive 19-Nov-2013
EP-2873740-A1 Methods for the surveillance, diagnosis and screening of bladder cancer Inactive 19-Nov-2013 C12Q1/6886
To view OncoDiag’s complete patent history, request access »

OncoDiag Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoDiag Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Normandie Participations Venture Capital Minority
Paris Business Angels Angel Group Minority
SFINE Venture Capital Minority
Angels Santé Angel Group Minority
Normandie Business Angels Angel Group Minority
You’re viewing 5 of 6 investors. Get the full list »

OncoDiag FAQs

  • When was OncoDiag founded?

    OncoDiag was founded in 2013.

  • Where is OncoDiag headquartered?

    OncoDiag is headquartered in Miserey, France.

  • What is the size of OncoDiag?

    OncoDiag has 5 total employees.

  • What industry is OncoDiag in?

    OncoDiag’s primary industry is Diagnostic Equipment.

  • Is OncoDiag a private or public company?

    OncoDiag is a Private company.

  • What is the current valuation of OncoDiag?

    The current valuation of OncoDiag is .

  • What is OncoDiag’s current revenue?

    The current revenue for OncoDiag is .

  • How much funding has OncoDiag raised over time?

    OncoDiag has raised $4M.

  • Who are OncoDiag’s investors?

    Normandie Participations, Paris Business Angels, SFINE, Angels Santé, and Normandie Business Angels are 5 of 6 investors who have invested in OncoDiag.

  • Who are OncoDiag’s competitors?

    OncoCyte, DiaCarta, Owlstone Medical, Nucleix, and Biodesix are competitors of OncoDiag.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »